Optimized treatment algorithm in early rheumatoid arthritis: methotrexate and intra-articular glucocorticosteroid plus adalimumab or placebo in the treatment of early rheumatoid arthritis
Phase of Trial: Phase III
Latest Information Update: 01 Jul 2018
At a glance
- Drugs Adalimumab (Primary) ; Methotrexate; Triamcinolone
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms OPERA
- 01 Jul 2018 Results of post-hoc analysis from CIMESTRA and OPERA trials published in the Scandinavian Journal of Rheumatology.
- 15 Nov 2017 Results published in The Journal of Rheumatology.
- 03 Oct 2016 Data presented at the American College of Rheumatology 2016 Annual Meeting, as per Myriad Genetics media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History